A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives

Aging is driven by interconnected genetic, epigenetic, molecular, and physiological processes spanning from unicellular to organismal levels. The surge in high-throughput data, from clinical and imaging to multi-omics, has outpaced traditional analysis methods; driving the integration of artificial intelligence (AI) into aging research. This comprehensive review examines the application of machine learning, deep learning, and computer vision across four canonical aging models (yeast, <i>Caenorhabditis elegans</i>, <i>Drosophila melanogaster</i>, and mice), highlighting AI's role in lifespan prediction, biomarker and gene discovery, aging-clock construction, and assay automation via automated animal counting and imaging. However, only 3% of the reviewed studies incorporated <i>in vivo</i> biological validation with common issues including small and imbalanced datasets, dataset bias, prediction noise, lack of cross-species analyses, absence of cytotoxicity testing, and overreliance on synthetic data. These drawbacks pose AI as just an aiding tool rather than a standalone solution, and without improvements in these sectors, AI-derived findings should be considered hypothesis generating rather than definitive conclusions. To address these issues, we propose the development of a standardized scoring system, AI Quality Assessment Metric (AI-QAM), for aging research that will evaluate studies on six criteria: (1) dataset size, (2) feature dimensionality, (3) biological validation type, (4) species diversity, (5) model generalizability, and (6) interpretability. Moreover, to mitigate the problem of lacking a unifying of a framework integrating AI approaches with biological mechanisms of aging, we present a conceptual framework, mapping AI applications across biological levels and aging hallmarks. AI will fulfill its potential in aging research only when it is firmly grounded in biological principles, systematically benchmarked, and rigorously validated through experimental studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Aging
Published
2026-01-28
DOI
https://doi.org/10.3389/fragi.2026.1644669
Primary Topic
Genetics, Aging, and Longevity in Model Organisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives

Salman Sohrabi, Tasnuva Binte Mahbub, Parsa Safaeian
Frontiers in Aging
Genetics, Aging, and Longevity in Model Organisms
article

A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives

Salman Sohrabi, Tasnuva Binte Mahbub, Parsa Safaeian
article en

Abstract

Aging is driven by interconnected genetic, epigenetic, molecular, and physiological processes spanning from unicellular to organismal levels. The surge in high-throughput data, from clinical and imaging to multi-omics, has outpaced traditional analysis methods; driving the integration of artificial intelligence (AI) into aging research. This comprehensive review examines the application of machine learning, deep learning, and computer vision across four canonical aging models (yeast, <i>Caenorhabditis elegans</i>, <i>Drosophila melanogaster</i>, and mice), highlighting AI's role in lifespan prediction, biomarker and gene discovery, aging-clock construction, and assay automation via automated animal counting and imaging. However, only 3% of the reviewed studies incorporated <i>in vivo</i> biological validation with common issues including small and imbalanced datasets, dataset bias, prediction noise, lack of cross-species analyses, absence of cytotoxicity testing, and overreliance on synthetic data. These drawbacks pose AI as just an aiding tool rather than a standalone solution, and without improvements in these sectors, AI-derived findings should be considered hypothesis generating rather than definitive conclusions. To address these issues, we propose the development of a standardized scoring system, AI Quality Assessment Metric (AI-QAM), for aging research that will evaluate studies on six criteria: (1) dataset size, (2) feature dimensionality, (3) biological validation type, (4) species diversity, (5) model generalizability, and (6) interpretability. Moreover, to mitigate the problem of lacking a unifying of a framework integrating AI approaches with biological mechanisms of aging, we present a conceptual framework, mapping AI applications across biological levels and aging hallmarks. AI will fulfill its potential in aging research only when it is firmly grounded in biological principles, systematically benchmarked, and rigorously validated through experimental studies.

Frontiers in AgingVol. 7
The University of Texas at Arlington (US)
National Institutes of Health
Openalex Percentile: Top 74%
Genetics, Aging, and Longevity in Model Organisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.